Skip to content

INTACS (Intrastromal Corneal Ring Segments) For Corneal Ectasia

INTACS (Intrastromal Corneal Ring Segments) For Corneal Ectasia

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02512432
Acronym
INTACS
Enrollment
1000
Registered
2015-07-30
Start date
2025-12-31
Completion date
2029-06-30
Last updated
2024-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus

Brief summary

To join established study put on by Addition Technologies, Inc. in the surgical implantation of asymmetrical INTACS segments to treat myopia and astigmatism in patients with keratoconus.

Detailed description

Use of asymmetrical corneal inserts to reduce or eliminate myopia and astigmatism in patients with keratoconus, who are no longer able to achieve adequate vision with their contact lenses or spectacles, so that their functional vision may be restored and the need for corneal transplantation may potentially be deferred.

Interventions

DEVICEINTACS

asymmetrical corneal inserts to reduce, or eliminate myopia and astigmatism in patients with keratoconus to decrease dependence on contact lenses and spectacle correction, while potentially deferring need for corneal transplantation.

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 21 years of age, or older * have experienced a progressive deterioration in their vision, such that they can no longer achieve adequate functional vision on a daily basis with contact lenses, or spectacles. * have clear central corneas * have a corneal thickness of 450 microns or greater at the proposed incision site * have corneal transplantation as the only remaining option to improve their visual function

Exclusion criteria

* under 21 years of age * have not experienced a progressive deterioration in their vision, such that they can no longer achieve adequate functional vision on a daily basis with contact lenses, or spectacles. * do not have clear central corneas * do not have a corneal thickness of 450 microns or greater at the proposed incision site * do not have corneal transplantation as the only remaining option to improve their visual function

Design outcomes

Primary

MeasureTime frameDescription
Corneal mapping to measure corneal thickness and steepening1 yearCorneal Topography

Contacts

Primary ContactOnnie Parker
oparker@ucsd.edu8588224848

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026